De-Risking a Biotherapeutic Product With HRMS HCP Analysis

Resources

Type: Case Study

De-Risking a Biotherapeutic Product With HRMS HCP Analysis

Learn more in our case study on how we used our advanced HRMS capabilities, detailed analytical outputs, and close, transparent communication to quickly identify high-risk proteins and advise process changes to de-risk a client’s biotherapeutic.  Read the Case Study Now:

Problematic Host Cell Proteins – Clusterin

When doing Host Cell Protein analysis by mass spectrometry, we often fail to appreciate the “why” of the HCPs that show up in our protein lists – why did these HCPs co-purify with the Product, and why are they important?   Clusterin shows up in almost every HCP project we work on. Why?

Shopping Cart